A New Era in the Treatment of Thyroid Eye Disease

American Journal of Ophthalmology
Amy PatelRaymond S Douglas

Abstract

Improved understanding of thyroid eye disease (TED) pathogenesis has facilitated identification of a targeted molecular approach for TED treatment offering the potential to halt or slow disease progression in a nonsurgical manner. Herein, we provide a summary of the current knowledge of TED management, followed by discussion of a novel insulin-like growth factor-1 receptor (IGF-1R) antagonist antibody and its potential to change the course of the disease. Perspective. Review of the literature and authors' experience. Many publications demonstrate IGF-1R overexpression in TED, and its activation as an autoantigen as a critical factor in TED pathogenesis. Several in vitro studies demonstrate that IGF-1R inhibition attenuates downstream molecular events including cytokine and hyaluronan production, and cellular differentiation. These observations led to the hypothesis that blocking IGF-1R may abrogate the clinical progression of TED. The recent completion of phase 2 and 3 randomized, placebo-controlled trials demonstrate the efficacy and safety of teprotumumab, a fully human monoclonal IGF-1R antagonist antibody, in patients with moderate-to-severe, active TED. Both the phase 2 and the recent phase 3 study results demonstrate that...Continue Reading

References

Jan 1, 1993·Autoimmunity·D R WeightmanP Kendall-Taylor
Feb 12, 1998·Thyroid : Official Journal of the American Thyroid Association·M N GerdingW M Wiersinga
Dec 25, 2003·The British Journal of Ophthalmology·J J ParkD A Perry-Keene
Jun 10, 2004·Thyroid : Official Journal of the American Thyroid Association·Michele MarinóClaudio Marocci
Sep 27, 2005·Clinical Endocrinology·G J KahalyU T Egle
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Raymond S DouglasTerry J Smith
Sep 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shanli TsuiTerry J Smith
Sep 16, 2008·Thyroid : Official Journal of the American Thyroid Association·Terry J SmithAndrew G Gianoukakis
Oct 4, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Raymond S DouglasTerry J Smith
Mar 10, 2009·BMJ : British Medical Journal·Petros PerrosJane Dickinson
Feb 1, 2007·Seminars in Plastic Surgery·Adel H Alsuhaibani, Jeffrey A Nerad
Jan 18, 2011·The Journal of Clinical Endocrinology and Metabolism·S ZangG J Kahaly
Jul 7, 2011·Current Opinion in Ophthalmology·Raymond S Douglas, Shivani Gupta
Feb 23, 2012·Current Neurology and Neuroscience Reports·Erin F GillespieRaymond S Douglas
May 29, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Terry J SmithRaymond S Douglas
Oct 6, 2012·The Journal of Clinical Endocrinology and Metabolism·L BartalenaUNKNOWN European Group on Graves' Orbitopathy
Jun 1, 2014·The Journal of Clinical Endocrinology and Metabolism·Hong ChenRaymond S Douglas
Oct 25, 2014·The Journal of Clinical Endocrinology and Metabolism·Marius N StanRebecca S Bahn
Dec 9, 2014·The Journal of Clinical Endocrinology and Metabolism·Christine C KriegerMarvin C Gershengorn
Dec 17, 2014·The Journal of Clinical Endocrinology and Metabolism·Mario SalviPaolo Beck-Peccoz
Sep 10, 2015·Journal of Ophthalmology·Jesús Barrio-BarrioJuan C Galofré
Nov 15, 2015·The British Journal of Ophthalmology·Jwu Jin KhongDinesh Selva
Apr 22, 2016·European Thyroid Journal·Luigi BartalenaUNKNOWN European Group on Graves' Orbitopathy (EUGOGO)
Nov 1, 2016·The New England Journal of Medicine·Terry J Smith, Laszlo Hegedüs
Jan 18, 2017·Frontiers in Endocrinology·Terry J Smith, Joseph A M J L Janssen
Jan 28, 2017·Expert Opinion on Therapeutic Targets·Terry Smith
Feb 9, 2017·Journal of Endocrinological Investigation·L BartalenaUNKNOWN European Group on Graves’ Orbitopathy (EUGOGO)
May 4, 2017·The New England Journal of Medicine·Terry J SmithRaymond S Douglas
Nov 1, 2017·Thyroid : Official Journal of the American Thyroid Association·Charlotte Ferløv-SchwensenLaszlo Hegedüs
Dec 24, 2017·Journal of Molecular Endocrinology·Michelle Mohyi, Terry J Smith
Aug 7, 2018·American Journal of Ophthalmology·Jose V Perez-MoreirasUNKNOWN Tocilizumab in Graves Orbitopathy Study Group
Jan 10, 2019·BMC Ophthalmology·Ewa Cyranska-ChyrekMarek Ruchala

❮ Previous
Next ❯

Citations

Dec 12, 2019·Ophthalmology and Therapy·Nickisa M Hodgson, Fatemeh Rajaii
Jul 28, 2020·Indian Journal of Ophthalmology·Santosh G Honavar
Jul 25, 2020·Expert Review of Clinical Immunology·Yongjing Ju, Junyi Yang
Nov 12, 2020·The British Journal of Ophthalmology·Amy Patel JainRaymond Douglas
Dec 6, 2020·Current Opinion in Neurology·Brooke T JohnsonVinay K Aakalu
Jan 29, 2021·Investigative Ophthalmology & Visual Science·Christine L HammondCollynn F Woeller
Nov 18, 2020·Anaesthesia and Intensive Care·Alfred Wy ChuaBrian P Harrisberg
Feb 18, 2020·Pharmacology & Therapeutics·Christine C KriegerMarvin C Gershengorn
Jul 28, 2020·Progress in Retinal and Eye Research·Min Joung LeeJames T Rosenbaum
Mar 21, 2021·International Ophthalmology Clinics·Christopher J Hwang, Kian Eftekhari
Apr 8, 2021·Ophthalmology·Richard C AllenMark J Lucarelli
May 1, 2021·The Medical Clinics of North America·Emily Li, Christopher B Chambers
May 6, 2021·Journal of the Endocrine Society·Chrysoula Dosiou, Andrea Lora Kossler
Jan 9, 2021·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Raymond S DouglasTerry J Smith

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Therapeutics and Clinical Risk Management
Yao WangRaymond S Douglas
Current Opinion in Ophthalmology
Zhen LiElizabeth Fortin
Current Opinion in Ophthalmology
Ajay E KuriyanSteven E Feldon
Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society
Dawn D YangVikram D Durairaj
Thyroid : Official Journal of the American Thyroid Association
Matthew R Edmunds, Kristien Boelaert
© 2021 Meta ULC. All rights reserved